PHF Chapters 11 and 12 Handout

CRTW 201

Dr. Fike

 

Work in groups to answer the following questions.  Group 1 starts with #1; group 2, with # 5; group 3, with #9; group 4, with # 13.  Find quotations to support your answers.  If you finish your 4 questions, work on some of the others.  You have 15 minutes.

 

Chapter 11

 

  1. Use two elements to fill in the following homology:

            Chapter 11:_______________::Chapter 12:_______________.

Q @ I in Chapter 11:

Q @ I in Chapter 12: 

  1. Which element is either absent or very downplayed in Chapter 11?  Why is this?
  2. What two main alternatives are there with respect to regulation (195)?
  3. What two major groups (points of view) oppose each other (198)?
  4. What principle (concept) do European countries emphasize more than the US does (2 words on 199)?
  5. Do an SEEI for the concept in #5.
  6. List five abuses (information) that resulted from lack of regulation in the 20th century (201).
  7. Nazi doctors’ experiments gave rise to what international regulation?  What does it stipulate?  What superseded it?  See 202.
  8. If you were a scientist for a biotechnology company, where would you want to field test your GMO?  What assumptions did you make in answering this question?
  9. According to Fukuyama, the unfettered advancement of technology is inevitable.  True or false?  Find evidence for your answer (200).
  10. Identify a sentence that expresses Fukuyama’s conclusion in this chapter (202).

 

Chapter 12 

  1. Discuss the following two statements.  Do you see a contradiction?  What do YOU think about the subject of these quotations?  Why?
    1. “…the time when governments could deal with biotech questions by appointing national commissions that brought scientists together with learned theologians, historians, and bioethicists…is rapidly drawing to a close” (203-04).
    2. “This implies the need to create a new agency to oversee the approval of new medicines, procedures, and technologies for human health.”  It should “include not just the doctors and scientists who staff the FDA and oversee clinical trials for new drugs, but other societal voices that are prepared to make judgments about the technology’s social and ethical implications” (213-14).

  13.  What does the concept of “capture” have to do with the issue in #12 (195, 204)?

  14.  What are the alternative uses to which biotechnology can be put (210)?  Which one does Fukuyama favor?  Do you agree?  Why?

  15.  What two alternatives complicate the relationship in #14 (209)?

  16.  What kind of future regulation does Fukuyama advocate?  See 213-14 (#12B), 215, and 218.  Do you find his prescription sufficient?  In other words, having finished the final chapter, do you have a clear

         picture of how we should regulate biotechnology?  See #12b and page 215. Do you consider his conclusion to be sufficient?

 

Other Questions

Use the elements to analyze the table of contents on page xi.

Find one sentence that seems to be Fukuyama's parting shot, the statement that he seems to want us to remember after finishing the whole book.